Erythropoietin/EPO is a renal cytokine that activates Akt and NF-kappaB signaling pathways by binding to erythroid progenitor cells EPOR. Erythropoietin/EPO regulates erythroid proliferation and differentiation and inhibits apoptosis. Erythropoietin/EPO also has angiogenic ability comparable to VEGF and can stimulate endothelial cell capillary sprouting. Erythropoietin/EPO can be used in the study of ischemic heart diseases such as anemia in end-stage renal disease. Erythropoietin/EPO Protein, Human (CHO) is a recombinant Erythropoietin/EPO protein expressed in CHO cells with tag-free.
Molecular Weight:
Approximately 26-38 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.
Purity:
98.00
Formula:
2056(Gene_ID)P01588 (A28-R193)(Accession)
Application Notes:
MCE Product type: Recombinant Proteins
* VAT and and shipping costs not included. Errors and price changes excepted
